Replies to post #757155 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

zero82

Thanks for asking 😶


LG is not a medical doctor and he does not treat patients or advise the families of patients…

But I do think “patients and families” might consider the work and expertise of some of these qualified medical professionals, oncology professors, and scientists:

✅️ Dr. Liau who is a world-renowned physician and currently serving on the SAB at NWBO

✅️ Dr. Kalinski at Roswell Park in New York

✅️ Dr. Puzanov at Roswell

✅️ The U.S. NIH and U.S. DoD who awarded continuing peer-reviewed grants

✅️ The independent JAMA peer reviewers

✅️ The independent Nature Comms peer reviewers

✅️ MHRA regulators who awarded approval of the PIP, approval of the MIA, and continue to support the Specials Program while the voluminous MAA is under review

✅️ Dr. Ashkan who was recently honored with an award from the U.K. government




“His work on brain cancer vaccines received the top presentation award by the British Neuro-Oncology Society in 2022 and promises to impact the care of patients with brain tumours worldwide.”

Consultant Neurosurgeon at @KingsCollegeNHS, Professor Keyoumars Ashkan, receives an MBE for services to neurosurgery.
 
In 2020, he removed patient Dagmar's brain tumour while she played her violin throughout the surgery. 👇pic.twitter.com/H2Z4LZic0h

— NHS London (@NHSEnglandLDN) December 31, 2024

https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/8/2/article-CASE24112.xml

https://www.kcl.ac.uk/news/professor-keyoumars-ashkan-awarded-mbe-in-kings-new-years-honours

https://www.bbc.com/news/uk-england-london-66378288

[XMaster2023]

NWBO doesn’t need NICE’s approval to begin treating patients. Only MHRA’s approval. To create 90 million in revenue NWBO would only need 450 patients per year which is a fraction of the quantity of patients in the UK and elsewhere that definitely could come up with the funds. You’re pushing your fudster analysis.